Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

13.76
+0.02000.15%
Post-market: 13.760.00000.00%16:05 EDT
Volume:34.16K
Turnover:471.31K
Market Cap:2.35B
PE:68.80
High:13.98
Open:13.78
Low:13.71
Close:13.74
Loading ...

RCM Technologies Expands HCM Software Services with UKG Ready Reseller Offering Empowering Small Businesses with All-In-One HCM Solutions

GlobeNewswire
·
25 Feb

Cytokinetics, Incorporated (CYTK): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey
·
24 Feb

High Growth Tech Stocks In The United States To Watch

Simply Wall St.
·
21 Feb

Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

Business Wire
·
21 Feb

Should You Invest in Edgewise Therapeutics (EWTX)?

Insider Monkey
·
19 Feb

HUTCHMED to Announce 2024 Final Results

GlobeNewswire
·
19 Feb

Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagliflozin to Reduce Major Adverse Cardiovascular Events (MACE)

GlobeNewswire
·
18 Feb

Press Release: Phenom Enterprise Cloud Acquired Pixentia to Bolster Leadership in Enterprise Digitalization and AI Innovation

Dow Jones
·
13 Feb

Breakfast News: UPST Is Just Getting Started

Motley Fool
·
12 Feb

Hutchmed price target raised to $27 from $26 at BofA

TIPRANKS
·
11 Feb

BofA Securities Adjusts Price Target on HUTCHMED (China) to $27 From $26, Maintains Buy Rating

MT Newswires Live
·
11 Feb

Bank of America Securities Remains a Buy on HUTCHMED (HCM)

TIPRANKS
·
11 Feb

Workday Named Best in KLAS for ERP (Large) for the Eighth Consecutive Year

PR Newswire
·
10 Feb

Why Cytokinetics, Incorporated (CYTK) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey
·
08 Feb

Baird Downgrades Paycor HCM to Neutral From Outperform, Adjusts Price Target to $22.50 From $28

MT Newswires Live
·
07 Feb

Analysts Are Neutral on These Technology Stocks: Paycor HCM (PYCR), Qualys (QLYS)

TIPRANKS
·
07 Feb

Paycor HCM Cut to Neutral From Outperform by Baird

Dow Jones
·
07 Feb

Hold Rating Sustained for Paycor HCM Amid Acquisition by PAYX, Reflecting Limited Upside Potential

TIPRANKS
·
07 Feb

Paycor HCM downgraded to Neutral from Outperform at Baird

TIPRANKS
·
07 Feb

Positive Outlook for Cytokinetics Amid Rising HCM Market Demand and Developments

TIPRANKS
·
07 Feb